...
首页> 外文期刊>Journal of Clinical Microbiology >Effects of Anticoagulant, Processing Delay, and Assay Method (Branched DNA versus Reverse Transcriptase PCR) on Measurement of Human Immunodeficiency Virus Type 1 RNA Levels in Plasma
【24h】

Effects of Anticoagulant, Processing Delay, and Assay Method (Branched DNA versus Reverse Transcriptase PCR) on Measurement of Human Immunodeficiency Virus Type 1 RNA Levels in Plasma

机译:抗凝剂,加工延迟和测定方法(支链DNA与逆转录酶PCR)对血浆中人类免疫缺陷病毒1型RNA水平测量的影响

获取原文
           

摘要

We conducted two studies to determine the potential influence of delays in blood processing, type of anticoagulant, and assay method on human immunodeficiency virus type 1 (HIV-1) RNA levels in plasma. The first was an experimental study in which heparin- and EDTA-anticoagulated blood samples were collected from 101 HIV-positive individuals and processed to plasma after delays of 2, 6, and 18 h. HIV-1 RNA levels in each sample were then measured by both branched-DNA (bDNA) and reverse transcriptase PCR (RT-PCR) assays. Compared to samples processed within 2 h, the loss (decay) of HIV-1 RNA in heparinized blood was significant (P < 0.05) but small after 6 h (bDNA assay, ?0.12 log10copies/ml; RT-PCR, ?0.05 log10 copies/ml) and after 18 h (bDNA assay, ?0.27 log10 copies/ml; RT-PCR, ?0.15 log10 copies/ml). Decay in EDTA-anticoagulated blood was not significant after 6 h (bDNA assay, ?0.002 log10 copies/ml; RT-PCR, ?0.02 log10copies/ml), but it was after 18 h (bDNA assay, ?0.09 log10 copies/ml; RT-PCR, ?0.09 log10copies/ml). Only 4% of samples processed after 6 h lost more than 50% (≥0.3 log10 copies/ml) of the HIV-1 RNA, regardless of the anticoagulant or the assay that was used. The second study compared HIV-1 RNA levels in samples from the Multicenter AIDS Cohort Study (MACS; samples were collected in heparin-containing tubes in 1985, had a 6-h average processing delay, and were assayed by bDNA assay) and the British Columbia Drug Treatment Program (BCDTP) (collected in EDTA- or acid citrate dextrose-containing tubes in 1996 and 1997, had a 2-h maximum processing delay, and were assayed by RT-PCR). HIV-1 RNA levels in samples from the two cohorts were not significantly different after adjusting for CD4+-cell count and converting bDNA assay values to those corresponding to the RT-PCR results. In summary, the decay of HIV-1 RNA measured in heparinized blood after 6 h was small (?0.05 to ?0.12 log10copies/ml), and the minor impact of this decay on HIV-1 RNA concentrations in archived plasma samples of the MACS was confirmed by the similarity of CD4+-cell counts and assay-adjusted HIV-1 RNA concentrations in the MACS and BCDTP.
机译:我们进行了两项研究,以确定血液处理延迟,抗凝剂类型和测定方法对血浆中人类免疫缺陷病毒1型(HIV-1)RNA水平的潜在影响。第一项是一项实验研究,其中从101位HIV阳性个体中收集了肝素和EDTA抗凝血样,并在延迟2、6和18小时后处理为血浆。然后,通过分支DNA(bDNA)和逆转录酶PCR(RT-PCR)测定法测量每个样品中的HIV-1 RNA水平。与2小时内处理的样品相比,肝素化血液中HIV-1 RNA的丢失(衰减)显着( P <0.05),但在6小时后很小(bDNA分析,≤0.12log 10 份/ml;RT-PCR,?0.05 log 10 拷贝/ ml)和18 h(bDNA分析,?0.27 log 10 拷贝/ ml) ; RT-PCR,?0.15 log 10 拷贝/ ml)。 EDTA抗凝血液在6小时后衰减不明显(bDNA分析,≤0.002log 10 拷贝/ml;RT-PCR,≤0.02 log 10 拷贝/ ml) ,但在18 h后(bDNA分析,?0.09 log 10 拷贝/ml;RT-PCR,?0.09 log 10 拷贝/ ml)。 6小时后处理的样品中,只有4%丢失了超过50%(≥0.3 log 10 拷贝/ ml)的HIV-1 RNA,无论使用何种抗凝剂或测定方法。第二项研究比较了多中心AIDS队列研究(MACS; 1985年在含肝素的试管中收集的样本,平均处理时间为6小时,并通过bDNA分析进行了分析)中的HIV-1 RNA水平。哥伦比亚药物治疗计划(BCDTP)(于1996年和1997年收集在含EDTA或酸性柠檬酸葡萄糖的试管中,最大处理延迟为2小时,并通过RT-PCR测定)。调整CD4 + -细胞计数并将bDNA测定值转换为与RT-PCR结果相对应的值后,两个队列样本中的HIV-1 RNA水平无明显差异。总之,肝素化血液在6 h后测得的HIV-1 RNA衰减很小(?0.05至≤0.12log 10 份/ ml),并且这种衰减对HIV-1的影响很小。 MACS存档血浆样品中的RNA浓度通过CD4 + -细胞计数与MACS和BCDTP中经检测调整的HIV-1 RNA浓度的相似性证实。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号